Purpose of the Review This review highlights recent developments into how intercellular communication through connexin43 facilitates bone modeling and remodeling. Recent Findings Connexin43 is required for both skeletal development and maintenance, particularly in cortical bone, where it carries out multiple functions, including preventing osteoclastogenesis, restraining osteoprogenitor proliferation, promoting osteoblast differentiation, coordinating organized collagen matrix deposition, and maintaining osteocyte survival. Emerging data shows that connexin43 regulates both the exchange of small molecules among osteoblast lineage cells and the docking of signaling proteins to the gap junction, affecting the efficiency of signal transduction. Summary Understanding how and what connexin43 communicates to coordinate tissue remodeling has therapeutic implications in bone. Altering the information shared by intercellular communication and/or targeting the recruitment of signaling machinery to the gap junction could be used to impact the skeletal homeostatic set point, either driving osteogenesis or inhibiting resorption.
touch, gap junctions form and facilitate direct cell-to-cell communication. The osteocyte itself would be comparable to the server, sending out information to the workstations (e.g., osteoblasts and their progenitors) on the bone surface. As such, the gap junction plays important roles in permitting, regulating, and responding to the shared data in the form of small molecules, ions, and second messengers.
It is becoming increasingly accepted that gap junctions regulate the data they permit to be communicated and acted on in numerous ways, including the monomeric composition of the gap junction channel, the relative abundance of the connexins, and the local recruitment of signaling machinery to the gap junction plaque. Gap junctions form from the assembly of connexin monomers. Each connexin has four transmembrane domains, two extracellular loops, and intracellular N-and C-terminal domains. Connexin protein hexamers in the plasma membrane form a hemichannel, also called a connexon. When a hemichannel in one cell aligns with a hemichannel in a neighboring cell, a gap junction pore is formed, creating an aqueous channel between the cytoplasm of the coupled cells. These gap junctions aggregate into larger gap junction plaques, composed of hundreds to thousands of gap junction channels [4, 5] . Humans have 21 genes encoding connexin proteins, and the specific connexin composition of a gap junction influences the size and charge selective permeability as well as the open/closed state probability of the channel [6, 7] . Further, most tissues, including bone, express multiple connexins and these can interact to form both hexameric Fig. 1 (e.g., mixed channels of connexin43 and connexin45) and heterotypic gap junctions (e.g., a connexin43 containing hemichannel docked to a connexin45 hemichannel) [8] . Thus, there is great plasticity in the molecules that can be exchanged by gap junctions. Another way that gap junctions can regulate intercellular communication is by regulating the relative abundance of connexins in a plaque, effectively tuning the bandwidth of the communication network with increasing gap junctions enhancing the efficiency of communication [9•] . Furthermore, emerging data support a model in which gap junctions not only serve as passive conduits for the intercellular exchange of small molecules, but gap junctions also assemble large complexes of signaling machinery. These signaling complexes not only regulate the open/closed state probability of the channel (affecting bandwidth), but may also serve as a docking scaffold for recruiting effectors of downstream signaling [10] [11] [12] . As with any effective communication, there must be a process to receive the communicated information. This pre-assembled complex of signaling machinery at the connexin43 plaque may serve this purpose. In addition, the assembly of specific signaling effectors to the gap junction permits even more specificity and control in regulating the data exchanged through this intercellular network.
Gap Junctions in Bone: the Skeletal Information Network
Connexin43 is the most abundant (and most studied) connexin present in the osteoblast lineage and allows passage of molecules and second messengers less than~1.2 kDa, with a preference for negatively charged molecules [13] [14] [15] [16] . There is growing evidence that connexin43 may be able to pass larger molecules, including siRNA or miRNAs with shapes permissive of traversing the gap junction channel [17, 18] . Other connexins are also expressed in osteoblast lineage cells, including connexin45, connexin46, and connexin37 [19] [20] [21] [22] , but a critical role for these other connexins in the osteoblast lineage has not been established. The gap junctions that form from connexin monomers occur not only between osteoblasts and osteoprogenitors on the bone surface but also at the long dendritic cell processes of osteocytes that extends through the canalicular network. The result is a functional syncytium of cells throughout the bone. It is through this network of cells that information is passed between cells in a gap junctiondependent manner to affect bone formation and resorption to ultimately impact bone quality. While much of what is known about connexin biology in the skeleton has been studied in the cells of the osteoblast lineage, osteoclasts also express several gap junction proteins, including connexin37 and connexin43 [22] [23] [24] . A skeletal phenotype has been reported in osteoclast lineage knockouts connexin37 in vivo [22] . Interestingly, despite the overlap in connexin expression, there is little evidence that the osteoblasts and osteoclasts directly communicate via gap junctions. Since the connexin in these boneresorbing osteoclasts do not appear to be directly plugged in to the intercellular communication syncytium of osteoblasts, osteocytes, and their progenitors, we will not focus on them here.
Taking the Bone Cellular Network Offline: Models of Connexin-Mutation or Deficiency
The fundamental observations that connexins, connexin43 in particular, play an important role in bone function has come from several loss of function studies performed in animal models. These findings have been confirmed by the observation of a role for connexin43 in human diseases with musculoskeletal involvement, including oculodentodigital dysplasia and craniometaphyseal dysplasia [25, 26] . When the bone intercellular communication network is taken offline by connexin43 gene deletion in healthy mice, the consequences for the skeleton are reproducibly poor. Connexin43 global knockout mice exhibit delayed mineralization and brittle bones in the axial and appendicular skeleton, craniofacial abnormalities, and a cell-autonomous osteoblast dysfunction, including a failure to progress through differentiation [27] . These mice die at birth due to a cardiac defect [28] . This role for connexin43 in bone is evolutionarily conserved in zebrafish, in which gain and loss of function of connexin43 regulate fin ray segment length [29] [30] [31] [32] .
In order to assess post-natal connexin43 gene deletion, conditional deletion knockout mouse models have been generated using four different promoters to drive Cre recombinase at progressively later stages of osteoblast differentiation (Fig. 1c) . The Dermo1/Twist2-Cre mouse line was used to conditionally delete connexin43 in the cells of the early chondro-osteoblast lineage (cKO TW2 ) [33•] . cKO TW2 mice have smaller and hypo-mineralized skulls at birth, reduced chest cavity from shortened ribs, and a 12% reduction in whole-body BMD (bone mineral density). cKO TW2 mice have a striking cortical, but no trabecular phenotype, including a more than 40% increase in the cross-sectional area of the long bones at the mid-diaphysis. This is a result of increased periosteal osteoblast activity, leading to periosteal expansion, cortical thinning, and increased marrow cavity area due to a concomitant increase in endocortical osteoclast activation. This demonstrated that deletion of connexin43 early in the osteoblast lineage not only affects the activity of osteoblasts, which had a cell-autonomous differentiation defect, enhanced proliferation, and produced a disorganized collagenous matrix, but also affected osteoclast formation and function. Similarly, slightly milder results were observed using the 2.3 kb Col1a1-Cre mice to genetically delete connexin43 at a later stage in the osteoblast lineage (cKO Col1 ; Fig. 1c ). cKO Col1 mice have a 5% reduction in whole-body BMD, cortical thinning, and a 30% increase in the cross-sectional area at the diaphysis [34, 35] . These animals had a similar cellautonomous osteoblast differentiation defect and enhanced support of osteoclastogenesis [34] . Indeed, much of the cortical phenotype could be restored by administering antiresorptive bisphosphonates to these animals, indicating that the role of connexin43 in bone is not only to coordinate osteoblast differentiation and function, but also that communicating networks of bone cells suppress osteoclast activation [36] . Conditional knockouts using the human osteocalcin-Cre mice (cKO hOC ) allowed connexin43 knockout to be restricted to mineralizing (late-stage) osteoblasts and osteocytes (Fig. 1c) . Consistent with the progressively less pronounced skeletal phenotype when connexin43 deletion occurred later in the osteoblast differentiation stage, these cKO hOC mice had only slightly diminished BMD (albeit only <4%) and only a~25% increase in the cross-sectional area at the diaphysis, but without cortical thinning in cKO hOC mice compared to that in wild type mice [37•, 38] . The fourth conditional knockout model was generated using the 8 kb DMP1-Cre mice (cKO DMP1 ), which is expressed almost exclusively in mature osteoblasts/ osteocytes (Fig. 1c) [37•, 38] . The cKO DMP1 mice have no cortical thinning or decrease in whole-body BMD along with no trabecular phenotype. cKO DMP1 mice do exhibit a 20% increase in the diaphysis cross-sectional area, resulting from increased osteoclast number. This model also exhibits a disorganized collagenous extracellular matrix with inferior material properties [38, 39] . Enhanced osteocyte apoptosis was observed in this model, underscoring an additional role for connexin43 in osteocyte cell survival [37•] . Notably, mouse models of oculodentodigital dysplasia, a disease caused by loss of function mutations in connexin43, have largely recapitulated the findings of connexin43 conditional deletion models, including osteopenia, an expanded cortical crosssectional area with a widened marrow cavity, and a bone with impaired material properties [33•, 40-42] .
A common theme in these models of connexin43 deficiency in the osteoblastic lineage is reduced bone mass, cortical widening, and reduced cortical thickness. Another consistent finding is an increase in bone resorption, caused by alterations in the production of osteoclastogenic factors by osteoblasts and osteocytes. These findings confirm connexin43 as an important regulator of osteoblastogenesis and the production of osteoclastogenic factors by osteoblasts and osteocytes, especially in the cortical bone. It is also notable that aspects of the phenotype are more pronounced the earlier in differentiation that connexin43 is deleted. The demonstration of the altered proliferative capacity of osteoprogenitors in the cKO TW2 model is unique among the osteoblast lineage conditional knockout models and implies that connexin43 plays a role in restraining proliferation in early osteoprogenitor populations (Fig. 1c) [33•] . A cell-autonomous defect in osteoblast differentiation was exclusive to the models of connexin43 deletion early in the lineage (i.e., cKO Col1 and cKO TW2) (Fig. 1c ) [33•, 34] . In the cKO DMP1 model, connexin43 expression is obligated for osteocyte cell survival, as osteocyte apoptosis was substantially increased in connexin43-deleted cells (Fig. 1c) [37•] . A similar observation of connexin43-dependent support of osteocyte survival was made in cKO hOC mice [43] . In addition, a loss of connexin43 in this model promoted osteocytic osteolysis in this model [44] . Interestingly, aspects of the skeletal phenotypes in these mice are similar to osteocyte ablation studies (e.g., fragile bones with increased cortical porosity, decreased cortical BMD, and osteoblast dysfunction) [45] [46] [47] [48] . A computer simulation of the intercellular communication between osteocytes and bone cells on the bone surface predicted that even a modest 5-9% level of osteocyte apoptosis would have a 25-37% reduction in the signaling received at the cell surface [49] . This suggests that at least some signals communicated through this cellular network travel through osteocytes to target the effector cells (i.e., osteoblasts, osteoclasts, and their progenitors). Not only that, the osteoblast-stage specific progressive skeletal phenotype supports a role for connexin43 throughout the lineage, including osteoprogenitors, osteoblasts, and osteocytes, underscoring bone as a coordinated remodeling unit.
The effects of defective intercellular communication caused by loss of connexin43 in bone become more complex in aging, loading, and disuse (reviewed [50] [51] [52] ). Thus, it is clear that data exchanged through this intercellular communication network is dynamic. The signals passed in healthy animals likely fundamentally differ from those in an aged animal, under mechanical load stimuli, or in disuse. Understanding the code of communicating anabolic and catabolic data signals will allow us to hack the systems to modulate bone responses.
Connexin43's Mechanisms of Action: Identifying Data Packets and Downstream Effectors
The need for this elaborate communication network in bone is most evident in the coordinated bone formation process, in which hundreds of osteoblasts in a local area become activated to deposit and mineralize the extracellular matrix. One of the key roles of connexin43 in this process is likely the ability to detect, amplify, and coordinately respond to subtle signals relative to background noise. This concept has been beautifully demonstrated in mammary epithelial cells, where gapjunctional communication among cells was shown to enable detection of shallow concentration gradients of epidermal growth factor that could not be sensed by a single cell by improving the efficiency of the signaling relay among cells [53] . In this context, the exchanged data was in the form of Ca 2+ signaling. Indeed, bone cell networks of osteocytes and osteoblasts have been shown to exchange Ca 2+ -dependent signals in response to hormonal, growth factor, and mechanical cues [54] [55] [56] [57] . But, Ca 2+ is not the only data that this network exchanges. Connexin43 has been shown to be involved directly or indirectly in the regulation of signaling cascades involving low molecular weight second messengers, like cAMP, inositol polyphosphates, and ATP [58•, 59•, 60, 61] . Interestingly, ATP release and the release of prostaglandin E2 have been shown to occur through unpaired hemichannels of connexin43 [60, 62, 63] . In a transgenic model of mutant connexin43 overexpression in osteocytes, a dominantnegative connexin43 construct (connexin43 Δ130-136) that blocked both gap junctions and hemichannels recapitulated the increase in cortical cross-sectional area, endocortical resorption, and osteocyte apoptosis that is observed in models of connexin43 deficiency [64•] . These phenotypes were not observed when a dominant-negative construct (connexin43 R76W) that only blocked gap-junctional communication, not hemichannels, was expressed in osteocytes. These data strongly indicate that connexin43 hemichannel activity is a driving force behind osteocytic signaling in this context. This interpretation is not without controversy as closely related pannexin channels have also been implicated in ATP release from these cells [65] .
The downstream effectors of connexin43 in the bone include various signaling pathways, including ERK, PKCδ, β-catenin, and protein kinase A [9•, 58•, 66-70] (Fig. 1c) . The connexin43-dependent effect on ERK and PKCδ regulate the transcriptional activity of Runx2, a master regulator of osteoblast differentiation, with increased connexin43 levels promoting Runx2 activity driving the expression of several osteoblast genes and vice versa (Fig. 1c ) [9•, 59•, 66, 67] . Similarly, the connexin43-dependent effect on ERK impacts the recruitment and activity of the transcriptional activator Sp1, the required osteoblast transcription factor osterix/Sp7, and osteocyte survival (Fig. 1c) [68, [71] [72] [73] [74] . Loss of osteocyte connexin43 has been shown to increase β-catenin, which has been speculated to prime endocortical bone formation in response to mechanical load [70] . Communication of cAMP through connexin43 gap junctions activates protein kinase A-dependent cascades to increase expression of the pro-osteoclastogenic signal, RANKL, and suppress sclerostin, an inhibitor of osteogenesis through the Wnt/β-catenin pathway (Fig. 1c) [58•] . Consistent with this finding, loss of connexin43 in vivo has been shown to attenuate the bone anabolic actions of parathyroid hormone, which acts in part via the cAMP/protein kinase pathway [34] . The role of connexin43 in this effect appears to be more in the osteoblasts than in osteocytes, as this effect is observed in connexin43 deficiency in early osteoblasts and osteocytes (cKO Col1 ), but not in cKO DMP1 mice lacking connexin43 only in the mature osteoblast/osteocyte compartment [34, 39] .
Undoubtedly, these second messengers and signaling pathways are not comprehensive, nor is it likely they are all operant under all conditions. Different stimuli are likely to elicit very different second messengers and signaling cascades. Indeed, such diversity in signals likely explains the differential roles for connexin43 in load, aging, disuse, hormonal signal, fracture healing, and even differences in function on the periosteal versus endocortical surfaces of bone. Regardless, in healthy adult animals, the role of connexin43 in the osteoblast lineage seems to be to inhibit osteoclastogenesis, suppress osteoblast proliferation, support early osteogenic differentiation, and promote osteocyte survival (Fig. 1c) . In the absence of connexin43, there is an expansion of the progenitor pool and a bottleneck as these cells fail to differentiate effectively. This expansion of the progenitor pool combined with the deposition of a disorganized collagenous extracellular matrix leads to poor bone quality.
Connexin43 as a Docking Platform: a Firewall for Regulating Which Communicated Data Is Acted on
While gap junctions are generally thought of as passive conduits for small molecules to be shared between cells, growing evidence indicates that connexins actively contribute to downstream signaling. Numerous protein complexes, including kinases associated with signal transduction cascades, assemble on the connexin43 C-terminus [10] [11] [12] . This led to the intriguing notion that, in order for efficient signaling to occur following the exchange of small molecules through the gap junction pore, the signal machinery must be spatially recruited to the gap junction plaque to be available to initiate a response. This also implies an additional level of control where data can be communicated, but not responded to if the appropriate signaling machinery is not present at the gap junction plaque. In support of this model, several of the signaling molecules involved in osteoblasts and osteocyte signaling have been shown to bind to the connexin43 C-terminus. In MC3T3 osteoblasts, PKCδ transiently binds to the connexin43 Cterminus and upon stimulation, translocates to the nucleus where it can regulate Runx2 transcriptional activity [59•] . In OB-6 cells, interactions between connexin43 C-terminus and β-arrestin allow survival from apoptosis from PTH, by sequestering β-arrestin and allowing cAMP-dependent cascades to be activated [69] . Lastly, in MLO-Y4 osteocyte-like cells, the connexin43 C-terminus interacts with α5β1 integrin, which controls the opening and closing of the hemichannels by causing a conformational change in the extracellular domain of the integrin in response to mechanical load, leading to activation of AKT signaling [75•] .
Further validating this model of the local recruitment of signaling machinery to the connexin43 C-terminus for efficient signal transduction, the connexin43 Cterminus is required (necessary but not sufficient) for the efficient activation of the ERK and PKCδ signaling cascades, activation of Runx2 transcriptional activity, and the expression of osteoblast genes [9• ]. An in vivo model of connexin43 C-terminal truncation (connexin43 K258Stop) had reduced the trabecular bone, but surprisingly, no changes in the cortical cross-sectional area or marrow area in female mice [76•] . Careful inspection did reveal a cortical phenotype in these mice that included decreased crystallinity and fracture toughness [77] .
Hacking the Network: Modulating Communicated Molecules to Impact Bone Quality
Bone forms an elaborate communication network with osteoblast, osteocytes, and osteoprogenitors sharing data. The communication of this data throughout the network plays a key role in how bone modeling and remodeling occurs. It has become clear that taking the cellular network offline by loss of connexin43 function has negative consequences for the skeleton, at least in healthy mice. But the mechanisms leading to these effects are less clear. We have only begun to scratch the surface of the actual data being communicated through these cells. Cracking the code of the data passing through this network will have obvious implications into bone therapeutic targets. For example, if we can hack the communication network to communicate data informing the skeleton that it is under load, even during disuse, we can have a profound impact on skeletal fragility and the maintenance of bone mass. The emerging data that this communicated data is diverse, with multiple targets, acting differently in distinct skeletal compartments, and in response to a broad array of extracellular cues only enhances the need to understand this fundamental process in bone homeostasis.
